Phathom Pharmaceuticals CEO Terrie Curran's 2020 pay jumps 34% to $4.6M
Phathom Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 6, 2021
Phathom Pharmaceuticals reported fiscal year 2020 executive compensation information on April 6, 2021.
In 2020, three executives at Phathom Pharmaceuticals received on average a compensation package of $3M, a 151% increase compared to previous year.
Average pay of disclosed executives at Phathom Pharmaceuticals
Terrie Curran, Chief Executive Officer, received $4.6M in total, which increased by 34% compared to 2019. 71% of Curran's compensation, or $3.3M, was in option awards. Curran also received $357K in non-equity incentive plan, $499K in salary, $483K in stock awards, as well as $10K in other compensation.
Azmi Nabulsi, Chief Operating Officer, received a compensation package of $2.4M, which increased by 345% compared to previous year. 56% of the compensation package, or $1.3M, was in option awards.
Todd P. Branning, Chief Financial Officer, earned $2M in 2020.
Related executives
You may also like
Source: SEC filing on April 6, 2021.